(1 - 30 von 71
)
Die Auswirkungen des EU-Pharma Pakets auf die Praxis –...
www.pressebox.de
IQPC GmbH, Dieses Jahr soll das EU-Pharma Paket endgültig verabschiedet werden. Für die Pharmakovigilanz bedeutet dies eine komplet...
Ireland in line to take on EU pharma body | Ireland | The Times
www.thetimes.co.uk
The size of Ireland's pharma sector could put it in a strong position in the race to become the new home of the EU's London-based medicines ...
"Das EU-Pharma-Paket - Was drinnen steckt!" | Pharmig,
www.ots.at
Neue Ausgabe von PHARMIG info mit gesundheitspolitischen Themen
Sensibilität bei der Ausformung einer eigenen EU APA-OTSwww.ots.at › presseaussendung › OTS_ _OTS0183 › sensibilitaet...
www.ots.at
— EU-Kommission präsentierte heute ihre EU-Pharma-Strategie. Für Arzneimittelzugang und eine rege Forschungstätigkeit ist ein sensibles ...
C5 - 3rd EU Pharma Law & Regulation Conference | Past Eventswww.crowell.com › NewsEvents › C5-3rd-EU-Phar...
www.crowell.com
2012 is set to be a critical year for EU pharma regulation with the implementation of the pharmacovigilance rules, proposals to amend the data protection ...
EU Pharma Law - The Royal Society of Chemistrywww.rsc.org › events › detail › eu-pharma-law
www.rsc.org
EU Pharma Law November 2008, Geneva, United Kingdom. Introduction. The Essential Guide to the Lastest Legal and Regulatory Developments ...
C5 - 3rd EU Pharma Law & Regulation Conference | Events | Crowell &...
www.crowell.com
C5 - 3rd EU Pharma Law & Regulation Conference. September , • Brussels, Belgium is set to be a critical year for EU pharma regulation with ...
C5's EU Pharma Law & Regulation
www.rsc.org
C5's EU Pharma Law & Regulation April 2008, London, United Kingdom. Introduction. C5's two day event is the essential one-stop shop providing you ...
Creation of a public EU pharma R&D infrastructure: Purpose and ...www.europarl.europa.eu › thinktank › events › details › creation-of-a-publ...
www.europarl.europa.eu
— Creation of a public EU pharma R&D infrastructure: Purpose and feasibility. Workshops STOA. Room SPAAK 7C50 and remotely.
HERA must address outstanding weaknesses in EU pharma ...www.medicinesforeurope.com › news › hera-must-a...
www.medicinesforeurope.com
HERA must address outstanding weaknesses in EU pharma framework to be successful. Brussels September Medicines For Europe strongly supports the ...
EU Pharma Regulatory Law | Events | Finnegan | Leading Intellectual...
www.finnegan.com
Finnegan partner Anthony C. Tridico, Ph.D. will present on
Discussion of the EU Pharma Package in the European Council of...
www.gmp-compliance.org
The EC pharma package meant to combat counterfeit medicinal products and amending Directive EC has now been discussed in the European Council of...
Innovation or stagnation? EU pharma industry at a crossroads ...www.euractiv.com › section › all › news › innovatio...
www.euractiv.com
EU pharma industry at a crossroads ahead of rules revision. By Barbora Pištorová | EURACTIV.cz. Jul 8, (updated: Jul 11, 2022).
New EU Pharma Strategy an encouraging sign towards building a ...cefic.org › media-corner › newsroom › new-eu-pha...
cefic.org
New EU Pharma Strategy an encouraging sign to help build a resilient and sustainable EU health industry. Brussels, 26 November – The European ...
Kurt Karst speaking at C5 EU Pharma Regulatory Law conference.
hpm.com
Kurt Karst speaking at C5 EU Pharma Regulatory Law conference. Co-presenter: Demystifying the Scope and Potential Impact of Proposed Legislation on Biosimilars to Enable You to Make Strategic Decisions Now. When. September 25, Kurt Karst is a co-presenter for the session on “Demystifying the Scope and ...
C5's 3rd Forum on EU Pharma Regulatory Law | Eventswww.squirepattonboggs.com › events › › c...
www.squirepattonboggs.com
· Squire Sanders is pleased to participate in C5's 3rd Forum on EU Pharma Regulatory Law, taking place September in Brussels.
An EU Pharma Policy Framework for Better Access to Affordable ...www.medicinesforeurope.com › news › an-eu-phar...
www.medicinesforeurope.com
— 23 February EU Pharma strategy provides unique moment to establish a regulatory… Factsheet: Boosting affordable innovations 21 May
Path to net-zero: EU pharma accelerates pledges while US plays ...www.spglobal.com › latest-news-headlines › path-to...
www.spglobal.com
— Path to net-zero: EU pharma accelerates pledges while US plays catch-up ... A common goal for drugmakers on both sides of the Atlantic is to reach ...
€2 billion poured into EU pharma innovation – EURACTIV.com
www.euractiv.com
A joint Commission-pharma industry research initiative to speed up the development of new drugs and cut down development costs began operating on 30 April...
Counterfeit of medicines causes 37,000 job losses in EU Pharma...
www.gmp-compliance.org
Counterfeit medicine is an increasing problem for public health and economy. This is no longer a problem of certain regions such as Asia and Africa. It has now...
Regulatory Recon: EU to Keep Pharma, Device Industries Under DG Sanco...
www.raps.org
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Brexit vote creates new uncertainty for UK, EU pharma industry -...
www.chemdiv.com
Brexit vote creates new uncertainty for UK, EU pharma industry
EU pharma companies may be required to disclose side-effects data,...
www.manufacturingchemist.com
If they are challenged by patients who have had adverse effects after taking a medicine.
EU Pharma Law & Regulation | Publications and Presentations | Arnold...
www.arnoldporter.com
For additional conference information please visit the link below: http://www.c5- online.com/pharmalaw/PR02.htm (link no longer active).
EU pharma stakeholders take action to tackle fake medicines –...
www.euractiv.com
A number of pharma stakeholders announced on 9 February the official launch of the European Medicines Verification System (EMVS), which ...
EU pharma associations seek orphan drug reform
www.manufacturingchemist.com
One key issue is the need to demonstrate that an orphan medicine has a significant benefit over existing treatments.
sortiert nach Relevanz / Datum